EVOQUE MEDICAL LTDActive

Company number 08106185Private limited companyIncorporated 2012
⚠ Accounts overdue. The next accounts were due on 31 Jul 2026 and had not been filed when the register was last updated.

Key figures

£69,205-23.6%
Net assets 2023/24
-1.8%
Average annual change 2020/21–2023/24
050 k100 k150 k2020/212021/222022/232023/24

Like most small UK companies, EVOQUE MEDICAL LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2023/24
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k2020/212021/222022/232023/24
Filed accounts2020/21–2023/24
2020/212021/222022/232023/24
Cash at bank and in hand43,108139,177106,34061,360
Total assets136,206175,277160,549176,658
Total liabilities63,03862,91669,918107,453
Net assets / total equity73,168112,36190,63169,205
Average number of employees3221

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: EVOQUE MEDICAL LTD

Company

EVOQUE MEDICAL LTD is a private limited company registered with Companies House under company number 08106185. It was incorporated on 14 Jun 2012. Its status is active. The registered office is in Manchester (M2). Its nature of business (SIC 2007) is general medical practice activities (86210).

Accounts

The latest accounts in the database are for 2023/24 (period ending 30 Apr 2024); the company files small company accounts (filleted). Net assets were £69,205, down 23.6% on the previous year. Cash at bank and in hand was £61,360. Total assets were £176,658 and total liabilities £107,453. The company had an average of 1 employee. Figures are available for 4 financial years (2020/21–2023/24).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Jul 2026. The next confirmation statement is due by 23 May 2027.